Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs XYL✓SelectedUSD · XYLGSK vs XYL performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs XYL

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+41.1%
XYL return
-22.4%
Excess return
+63.5%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioXYLExcessAlpha
1D-0.1%-0.6%+0.5%0.0%
7D-5.3%+0.5%-5.8%-5.4%
30D-3.7%-11.0%+7.3%-1.6%
3M-7.3%-16.2%+9.0%-4.2%
6M-4.2%-11.9%+7.6%-2.2%
YTD+0.9%-29.7%+30.6%+7.8%
1Y+7.3%-30.5%+37.7%+14.9%
3Y+52.7%-2.3%+55.0%+50.9%
All+41.1%-22.4%+63.5%+42.9%

Cumulative growth

Daily Returns

Daily percentage return beside XYL.

Daily Out/Under-Performance

Portfolio return minus XYL return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × XYL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded XYL wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling